Opioids in Cancer Pain

Cleveland Clinic Foundation, OH. Covers principles of opioid pharmacodynamics, pharmacokinetics, and pharmacogenetics; and discusses complex issues and debate surrounding the use of opioids. Features new chapters on opioids in pediatrics and developing countries. For clinicians. Previous edition: c2005.

Mel Davis is Director of Research at the Harry R. Horvitz Center of Palliative Medicine, Taussig Cancer Center, Division of Solid Tumor, Cleveland Clinic, USA. He also holds the positions of Editor-in-Chief of Progress in Palliative Care, and Chairman of the Palliative Section, Multinational Association of Supportive Care in Cancer. His research interests are in pain management, cancer pain, palliative medicine, symptom control and supportive cancer care.
Paul Glare is a Senior Staff Specialist Physician at Royal Prince Alfred Hospital (RPAH) in Sydney, Australia. He is Head of the Dept of Palliative Care at RPAH, and Head of Palliative Care Services for Sydney Cancer Centre and the eastern zone of Sydney South West Area Health Service (population 500,000). He is also Clinical Associate Professor of Medicine (Central Clincial School) at the University of Sydney.
Janet Hardy is the Director of Palliative Medicine for the Mater Health Services and is the Clinical Research Programme Leader for the Centre for Palliative Care Research and Education in Brisbane. She holds a chair in Palliative Medicine from the University of Queensland School of Medicine.
Columba Quigley previously held the post of Deputy Coordinating Editor of the Cochrane Collaboration Pain Palliative and Supportive Care Group. She has lectured and published in a range of areas, including opioid switching, alternative opioids, inter-individual variability in opioid responsiveness and the genetics of opioid response.